Intermediatecell biology
Exosome Biology: Messages in Vesicles
Overview
Exosomes are 30–150 nm extracellular vesicles released when multivesicular bodies fuse with the plasma membrane. They carry proteins, lipids, and RNAs between cells — roles in immunity, cancer, and promising diagnostics.
Learning objectives
- Define exosomes vs. other vesicles
- Explain exosome biogenesis via MVBs
- Describe cargo and functions
- Evaluate diagnostic potential
What exosomes are
Exosomes form as intraluminal vesicles inside multivesicular bodies (via ESCRT machinery); when the MVB fuses with the plasma membrane, they're released. Distinct from microvesicles (plasma-membrane budding) and apoptotic bodies.
Exosome = MVB origin. Microvesicle = plasma membrane budding. Size and origin define them.
Cargo
Tetraspanins (CD63, CD81), heat-shock proteins, miRNAs, mRNAs, and even DNA fragments. Cargo is selectively sorted — not random cellular debris.
CD63/CD81/CD9 tetraspanins are the classic exosome markers.
Functions
Immune regulation (dendritic-cell exosomes present antigen), cancer progression (tumor exosomes prepare metastatic niches), neuronal communication, and waste disposal.
Tumor exosomes can promote metastasis — but also expose tumor antigens for immunotherapy.
Liquid biopsy promise
Exosomes in blood, urine, and saliva carry disease signatures — cancer mutations, neurodegenerative proteins. They cross the blood-brain barrier, offering windows into brain pathology.
Exosomes are circulating message bottles — diagnostics is their most immediate application.
Therapeutic vehicles
Engineered exosomes are being tested as drug-delivery vehicles — natural targeting, low immunogenicity, BBB penetration. Clinical trials are underway.
Exosome therapeutics: loading siRNA or drugs into vesicles for targeted delivery.
Key points
- 30–150 nm, MVB-derived
- ESCRT builds intraluminal vesicles
- Carry miRNA and proteins selectively
- Mediate immune and cancer signaling
- Promising liquid-biopsy markers
Common misconceptions
✓ Truth: Cargo is selectively sorted and functionally delivered — they're communication, not waste.
✓ Truth: Microvesicles and apoptotic bodies differ in origin, size, and composition.
Practice questions
Q1. Exosomes are released when ___ fuses with the plasma membrane:
- Multivesicular bodies
- Lysosomes
- The nucleus
- Mitochondria
MVB–plasma membrane fusion releases intraluminal vesicles as exosomes.
Q2. Classic exosome markers include:
- CD63 and CD81 tetraspanins
- Histones
- Hemoglobin
- Insulin
Tetraspanins CD63/CD81/CD9 are enriched in exosomal membranes.
Q3. Tumor-derived exosomes can:
- Prepare pre-metastatic niches
- Cure cancer
- Replace chemotherapy
- Prevent all metastasis
Tumor exosomes condition distant sites for metastasis — a therapeutic target.
Click a question to reveal the answer and explanation.
Frequently asked questions
How do exosomes form?
ESCRT machinery buds intraluminal vesicles into endosomes, forming multivesicular bodies; when MVBs fuse with the plasma membrane instead of lysosomes, the vesicles are released as exosomes.
Why are exosomes promising for diagnostics?
They circulate in accessible fluids, carry cell-of-origin molecular signatures (mutant DNA, miRNAs), cross the blood-brain barrier, and protect cargo from degradation.
Distinguish exosomes from microvesicles.
Exosomes (30–150 nm) originate as intraluminal vesicles of MVBs; microvesicles (100–1000 nm) bud directly from the plasma membrane. Different biogenesis, overlapping sizes.